<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>e-sygoing.link — Research and Development</title>
  <link>https://e-sygoing.link</link>
  <description>Latest links in the Research and Development category</description>
  <language>en-us</language>
  <lastBuildDate>Sun, 24 May 2026 06:48:43 -0400</lastBuildDate>
  <atom:link href="https://e-sygoing.link/rss.php?type=new&amp;cid=87288"
             rel="self" type="application/rss+xml"/>
    <item>
    <title>ZymoGenetics, Inc.</title>
    <link>https://e-sygoing.link/link/5624338-zymogenetics-inc</link>
    <description>Discovery, development and commercialization of therapeutic proteins for the prevention and treatment of human diseases. Includes product pipeline, news on clinical trials and profile of company in Seattle, Washington.</description>
    <pubDate>Sat, 02 May 2026 13:38:32 -0400</pubDate>
    <guid isPermaLink="false">https://e-sygoing.link/go/5624338</guid>
  </item>
    <item>
    <title>Intra-Cellular Therapies, Inc.</title>
    <link>https://e-sygoing.link/link/5624327-intra-cellular-therapies-inc</link>
    <description>Developing novel drugs against targets inside nerve cells to treat CNS disorders. Includes therapeutic projects, target biochemistry, corporate data and contacts for headquarters in New York City.</description>
    <pubDate>Tue, 07 Apr 2026 17:05:57 -0400</pubDate>
    <guid isPermaLink="false">https://e-sygoing.link/go/5624327</guid>
  </item>
    <item>
    <title>Curis, Inc</title>
    <link>https://e-sygoing.link/link/5624319-curis-inc</link>
    <description>Developing small molecule and peptide drugs in regulatory signaling and regenerative pathways. Introduces technical background, product pipeline, collaborations, investment data and careers headquartered from Cambridge, Massachusetts. (Nasdaq: CVGP)</description>
    <pubDate>Mon, 06 Apr 2026 04:56:14 -0400</pubDate>
    <guid isPermaLink="false">https://e-sygoing.link/go/5624319</guid>
  </item>
    <item>
    <title>Xencor, Inc.</title>
    <link>https://e-sygoing.link/link/5624343-xencor-inc</link>
    <description>Technology for MHC epitope removal, glycosylation to optimize pharmacokinetics, masking immune recognition sites and engineering monoclonal antibodies. Includes discovery programs, partnering opportunities in Monrovia, California.    ImmunoPDAâ„¢ Technology Product Sheet      Caltech spin-off developing proteomic technologies to accelerate drug discovery.</description>
    <pubDate>Sat, 14 Feb 2026 20:10:29 -0500</pubDate>
    <guid isPermaLink="false">https://e-sygoing.link/go/5624343</guid>
  </item>
    <item>
    <title>Avigen, Inc.</title>
    <link>https://e-sygoing.link/link/5624315-avigen-inc</link>
    <description>Develops gene-based therapeutic products derived from adeno-associated virus for the treatment of inherited and acquired diseases. Includes explanation of technology, product pipeline, collaborative partnerships and investment data, from manufacturing facility in Alameda, California. (Nasdaq: AVGN)</description>
    <pubDate>Sat, 25 Oct 2025 00:31:18 -0400</pubDate>
    <guid isPermaLink="false">https://e-sygoing.link/go/5624315</guid>
  </item>
    <item>
    <title>Genentech, Inc.</title>
    <link>https://e-sygoing.link/link/5624323-genentech-inc</link>
    <description>Genetic engineering techniques in the discovery, development, production, and marketing of human therapeutics. Includes research history, product pipline, global corporate and career information, from South San Francisco, California.</description>
    <pubDate>Tue, 23 Sep 2025 07:23:30 -0400</pubDate>
    <guid isPermaLink="false">https://e-sygoing.link/go/5624323</guid>
  </item>
    <item>
    <title>Nymox Pharmaceutical Corp.</title>
    <link>https://e-sygoing.link/link/5624332-nymox-pharmaceutical-corp</link>
    <description>Researches and develops neurological diagnostics and pharmaceuticals for the aging population with emphasis on Alzheimer&#039;s disease. Profile of company with bases in Maywood, New Jersey and Saint Laurent, Quebec. (Nasdaq: NYMX)</description>
    <pubDate>Sat, 16 Aug 2025 21:33:57 -0400</pubDate>
    <guid isPermaLink="false">https://e-sygoing.link/go/5624332</guid>
  </item>
    <item>
    <title>Aphton Corp.</title>
    <link>https://e-sygoing.link/link/5624310-aphton-corp</link>
    <description>Develops products using vaccine-like technology for neutralizing hormones which participate in gastrointestinal system and reproductive system cancer and non-cancer diseases and the prevention of pregnancy. Based in Miami, Florida. (Nasdaq: APHT)</description>
    <pubDate>Tue, 08 Jul 2025 10:54:35 -0400</pubDate>
    <guid isPermaLink="false">https://e-sygoing.link/go/5624310</guid>
  </item>
    <item>
    <title>Praecis Pharmaceuticals Inc.</title>
    <link>https://e-sygoing.link/link/5624342-praecis-pharmaceuticals-inc</link>
    <description>Develops peptide-based therapeutics for the treatment of human hormone diseases, prostate cancer endometriosis, and inflammatory diseases. Includes therapeutic targets and profile of facilities in Waltham, Massachusetts. (Nasdaq: PRCS)</description>
    <pubDate>Tue, 17 Jun 2025 23:41:41 -0400</pubDate>
    <guid isPermaLink="false">https://e-sygoing.link/go/5624342</guid>
  </item>
    <item>
    <title>Xenova Group plc</title>
    <link>https://e-sygoing.link/link/5624336-xenova-group-plc</link>
    <description>Holding company for drug discovery subsidiaries, developing anti-cancer compounds in clinical stage, and addiction vaccines. Includes candidates for therapeutic focus, investor details, with contacts in Slough and Cambridge, England. (Nasdaq: XNVA)</description>
    <pubDate>Sat, 07 Jun 2025 07:53:47 -0400</pubDate>
    <guid isPermaLink="false">https://e-sygoing.link/go/5624336</guid>
  </item>
  </channel>
</rss>
